HLA TYPING USING OLIGONUCLEOTIDE ARRAYS

Information

  • Research Project
  • 6511115
  • ApplicationId
    6511115
  • Core Project Number
    R44AI044570
  • Full Project Number
    5R44AI044570-03
  • Serial Number
    44570
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/15/2001 - 24 years ago
  • Project End Date
    3/31/2003 - 22 years ago
  • Program Officer Name
    DUGLAS-TABOR, YVONNE
  • Budget Start Date
    4/1/2002 - 23 years ago
  • Budget End Date
    3/31/2003 - 22 years ago
  • Fiscal Year
    2002
  • Support Year
    3
  • Suffix
  • Award Notice Date
    3/27/2002 - 23 years ago
Organizations

HLA TYPING USING OLIGONUCLEOTIDE ARRAYS

APPLICANT?S DESCRIPTION: The objective of this proposal is to develop a commercial HLA (human leucocyte antigen) typing system using a microsphere-based DNA probe array. Characterization of HLA gene at DNA level has become a crucial tool in identifying HLA compatible donor-recipient pairs for successful human organ/marrow transplantation. Here, we describe an advanced yet tangible method of HLA typing for the five major HLA loci, HLA-A, B, C, DRB, and DQB to accommodate the needs of clinical laboratories. The microsphere-based array platform has a unique combined advantage of DNA probe array, and flexibility, cost-effectiveness, and sample processing capability of flow cytometry. Multi-analyte DNA hybridization assay using a panel of HLA locus-specific probe is conducted and analyzed in a single reaction. In phase II period, we will continue and expand probe development for both low and high resolution typing of the five major HLA loci, develop sample amplification method, develop data analysis software, and rigorously validate the final system through beta-testing. Flexibility, cost-effectiveness, and automation potential of the proposed system is expected fulfill the existing needs of HLA typing at DNA level for laboratories involved in solid organ transplant as well as high throughput screening for the national bone marrow donor registry. PROPOSED COMMERCIAL APPLICATION: Not Available

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R44
  • Administering IC
    AI
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    341676
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:341676\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ONE LAMBDA, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CANOGA PARK
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    913032801
  • Organization District
    UNITED STATES